ReviewCancers2022

New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations.

Julien Edeline et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.